Servier in the age of AI
https://servier.com/en/newsroom/digital-transofrmation-ai/
Publish Date: 2026-03-11 10:24:00
Source Domain: servier.com
-
Key objectives of AI at Servier: AI is utilized to accelerate therapeutic innovation, provide new services to patients and health care professionals, and enhance efficiency and sustainability across the value chain.
-
Servier’s ambition: To become best-in-class by integrating digital technology, data, and AI, with a focus on therapeutic innovation, patient support, and operational excellence.
-
AI focus in R&D: AI resources are primarily used to expedite the discovery and development of new treatments, potentially reducing the time required to develop new medicines by 2-4 years.
-
AI in clinical trials: AI helps predict the behavior of molecules in the body and their potential toxicity through in silico tests, thereby improving the drug development process.
-
Strategic partnerships: Servier has formed several technology partnerships, including those with Insilico Medicine, Iktos, Owkin, Aitia, and Google Cloud, to accelerate the discovery of new therapies and leverage advanced AI technologies.
-
Role of data in AI success: Data quality and diversity are crucial in AI’s effectiveness, as highlighted by Virginie Dominguez, to ensure successful outcomes in drug development.
